Cargando…
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?: Pro: Provide pre-emptive treatment to asymptomatic carriers
Autor principal: | de Boer, Rudolf A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400733/ https://www.ncbi.nlm.nih.gov/pubmed/37493902 http://dx.doi.org/10.1007/s12471-023-01793-0 |
Ejemplares similares
-
Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?: Con: Do no harm to asymptomatic carriers
por: Doevendans, Pieter A.
Publicado: (2023) -
Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19
por: Bhatia, Meena, et al.
Publicado: (2021) -
Pro: Should Evidence-Based Medicine Be Used More in Clinical Practice?
por: Fee, Chris
Publicado: (2006) -
Pro: Integrated Five-Year Anesthesiology Residency Should Be Implemented Widely
por: Kovar, Alan J., et al.
Publicado: (2023) -
Rebuttal of Pro
por: Maxim, Preston
Publicado: (2006)